Abstract
Elevated arginine vasopressin (AVP) levels are associated with poor prognosis in cardiac and non-cardiac diseases. Copeptin, a fragment of pre-pro-vasopression, is a stable surrogate biomarker for AVP. In this secondary analysis of the Biomarkers in Acute Heart Failure (BACH) study, the prognostic
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
